Hedwig E. Deubzer

6.0k total citations · 1 hit paper
64 papers, 3.7k citations indexed

About

Hedwig E. Deubzer is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Hedwig E. Deubzer has authored 64 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 30 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in Hedwig E. Deubzer's work include Neuroblastoma Research and Treatments (36 papers), Histone Deacetylase Inhibitors Research (20 papers) and Protein Degradation and Inhibitors (17 papers). Hedwig E. Deubzer is often cited by papers focused on Neuroblastoma Research and Treatments (36 papers), Histone Deacetylase Inhibitors Research (20 papers) and Protein Degradation and Inhibitors (17 papers). Hedwig E. Deubzer collaborates with scholars based in Germany, United States and France. Hedwig E. Deubzer's co-authors include Olaf Witt, Ina Oehme, Till Milde, Marco Lodrini, Matthias Fischer, Annette Kopp‐Schneider, Andreas von Deimling, Frank Westermann, Johannes H. Schulte and Andreas E. Kulozik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Advanced Functional Materials.

In The Last Decade

Hedwig E. Deubzer

60 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HDAC family: What are the cancer relevant targets?

2008 871 citations Olaf Witt, Hedwig E. Deubzer et al. Cancer Letters profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hedwig E. Deubzer Germany	31	2.9k	1.1k	734	545	313	64	3.7k
Ina Oehme Germany	29	3.1k 1.1×	1.1k 1.0×	312 0.4×	268 0.5×	261 0.8×	65	3.6k
Volker Ehemann Germany	33	2.3k 0.8×	889 0.8×	413 0.6×	798 1.5×	100 0.3×	96	3.5k
Danilo Marimpietri Italy	30	1.5k 0.5×	578 0.5×	559 0.8×	459 0.8×	96 0.3×	67	2.6k
Mariateresa Fulciniti United States	34	2.6k 0.9×	1.5k 1.4×	92 0.1×	599 1.1×	272 0.9×	155	4.1k
James E. Bradner United States	28	3.6k 1.2×	1.3k 1.2×	93 0.1×	272 0.5×	148 0.5×	63	4.5k
Vita Golubovskaya United States	39	2.3k 0.8×	1.6k 1.5×	253 0.3×	705 1.3×	87 0.3×	93	4.3k
Tim C. P. Somervaille United Kingdom	29	3.3k 1.1×	654 0.6×	94 0.1×	435 0.8×	590 1.9×	105	4.4k
Keith Dredge United States	30	2.2k 0.8×	983 0.9×	108 0.1×	295 0.5×	359 1.1×	55	3.7k
Marie Le Mercier Belgium	27	1.8k 0.6×	757 0.7×	100 0.1×	576 1.1×	362 1.2×	56	3.0k
Enrique M. Ocio Spain	41	2.7k 0.9×	1.9k 1.8×	131 0.2×	344 0.6×	1.4k 4.4×	206	5.2k

Countries citing papers authored by Hedwig E. Deubzer

Since Specialization

Citations

This map shows the geographic impact of Hedwig E. Deubzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hedwig E. Deubzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hedwig E. Deubzer more than expected).

Fields of papers citing papers by Hedwig E. Deubzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hedwig E. Deubzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hedwig E. Deubzer. The network helps show where Hedwig E. Deubzer may publish in the future.

Co-authorship network of co-authors of Hedwig E. Deubzer

This figure shows the co-authorship network connecting the top 25 collaborators of Hedwig E. Deubzer. A scholar is included among the top collaborators of Hedwig E. Deubzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hedwig E. Deubzer. Hedwig E. Deubzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Michallek, Florian, Marc Dewey, Barbara Hero, et al.. (2025). Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free Survival. Radiology Imaging Cancer. 8(1). e250070–e250070.

Deubzer, Hedwig E., Anne Thorwarth, Theresa Thole, et al.. (2025). Pädiatrische Onkologie: Fortschritte in Diagnostik und Therapie. 31(2). 213–222.

Wu, Dongwei, Johanna Berg, Viola Röhrs, et al.. (2024). Bioprinting of Perfusable Vascularized Organ Models for Drug Development via Sacrificial‐Free Direct Ink Writing. Advanced Functional Materials. 34(30). 18 indexed citations

Thorwarth, Anne, Kathy Astrahantseff, Annabell Szymansky, et al.. (2024). Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma. Journal of Clinical Medicine. 13(19). 5995–5995. 1 indexed citations

Forbes, Martin, Guido Mastrobuoni, Matthias Pietzke, et al.. (2024). L-Glyceraldehyde Inhibits Neuroblastoma Cell Growth via a Multi-Modal Mechanism on Metabolism and Signaling. Cancers. 16(9). 1664–1664. 3 indexed citations

Schweizer, Leonille, Wolfgang Hartmann, Arend Koch, et al.. (2022). Evidence of neural crest cell origin of a DICER1 mutant CNS sarcoma in a child with DICER1 syndrome and NRAS‐mutant neurocutaneous melanosis. Neuropathology and Applied Neurobiology. 48(6). e12830–e12830. 6 indexed citations

Taube, Eliane T., Hedwig E. Deubzer, K Rothe, et al.. (2022). Management of malignant dysgerminoma of the ovary. European Journal of Gynaecological Oncology. 43(2). 353–353. 6 indexed citations

Thorwarth, Anne, Kerstin Haase, Claudia Röefzaad, et al.. (2022). Genomic Evolution and Personalized Therapy of an Infantile Fibrosarcoma Harboring anNTRKOncogenic Fusion. JCO Precision Oncology. 6(6). e2100283–e2100283. 3 indexed citations

Sprüssel, Annika, Kathy Astrahantseff, Karin Schmelz, et al.. (2020). Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction. Journal of Molecular Diagnostics. 22(11). 1309–1323. 11 indexed citations

10.

Thole, Theresa, Marco Lodrini, Thomas Hielscher, et al.. (2017). Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival. Cell Death and Disease. 8(3). e2635–e2635. 48 indexed citations

11.

Ackermann, Sandra, Barbara Hero, Yvonne Kahlert, et al.. (2013). Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma. Cell Death and Disease. 4(4). e586–e586. 159 indexed citations

12.

Brockmann, Markus, Evon Poon, Anne Carstensen, et al.. (2013). Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma. Cancer Cell. 24(1). 75–89. 223 indexed citations

13.

Henrich, Kai‐Oliver, Tobias Bauer, Johannes H. Schulte, et al.. (2011). CAMTA1 , a 1p36 Tumor Suppressor Candidate, Inhibits Growth and Activates Differentiation Programs in Neuroblastoma Cells. Cancer Research. 71(8). 3142–3151. 64 indexed citations

14.

Milde, Till, Ina Oehme, Andrey Korshunov, et al.. (2010). HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth. Clinical Cancer Research. 16(12). 3240–3252. 158 indexed citations

15.

Michaelis, Martin, Malte Kleinschmidt, Susanne Barth, et al.. (2009). Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines. Biochemical Pharmacology. 79(2). 130–136. 95 indexed citations

16.

Witt, Olaf, Hedwig E. Deubzer, Marco Lodrini, Till Milde, & Ina Oehme. (2009). Targeting Histone Deacetylases in Neuroblastoma. Current Pharmaceutical Design. 15(4). 436–447. 53 indexed citations

17.

Oehme, Ina, Hedwig E. Deubzer, Dennis Wegener, et al.. (2008). Histone Deacetylase 8 in Neuroblastoma Tumorigenesis. Clinical Cancer Research. 15(1). 91–99. 320 indexed citations

18.

Witt, Olaf, Hedwig E. Deubzer, Till Milde, & Ina Oehme. (2008). HDAC family: What are the cancer relevant targets?. Cancer Letters. 277(1). 8–21. 871 indexed citations breakdown →

19.

Deubzer, Hedwig E., Volker Ehemann, Frank Westermann, et al.. (2007). Histone deacetylase inhibitor Helminthosporium carbonum (HC)‐toxin suppresses the malignant phenotype of neuroblastoma cells. International Journal of Cancer. 122(8). 1891–1900. 38 indexed citations

20.

Deubzer, Hedwig E., Daniel Eikel, Martin Michaelis, et al.. (2006). Novel valproic acid derivatives with potent differentiation-inducing activity in myeloid leukemia cells. Leukemia Research. 30(9). 1167–1175. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact